For instance, in our current study, 3% of participants with a pathogenic MLH1 variant were found to have colorectal cancer, a percentage consistent with a previous report from the prospective LS database, indicating a colorectal cancer risk in MLH1 carriers ranging from 32.2% to 45.2% by the age of 60 [27]. Here, MLH1 is linked to colorectal cancer.